Value: stock screener
2.721 instruments: stocks, ETFs, REITs, closed-end funds, BDCs and crypto. Each is compared with its peers on published rules, refreshed every trading day.
Cheap against peers (Value ≥ 70) without weak fundamentals (Quality ≥ 30); stocks and REITs with no serious warnings, sorted by Value.
Filters · 1
Showing 10 of 58 matches (Free plan: the first 10)
as of 2026-10-15 06:20 UTC
| Instrument | Score | Value | Quality | Yield | P/E | P/B | 1 yr | Mkt cap | Warnings |
|---|---|---|---|---|---|---|---|---|---|
| AMNAMN Healthcare Services Inc | 9/10 | 100 | 61 | 0,0% | 13,9 | 2,0 | +82,0% | € 1,3 mld. | |
| INVAInnoviva Inc | 9/10 | 99 | 77 | 0,0% | 4,2 | 1,2 | +25,8% | € 1,4 mld. | Caution:Earnings quality |
| AMPHAmphastar Pharmaceuticals | 7/10 | 99 | 67 | 0,0% | 14,1 | 1,4 | +9,3% | € 991 mln. | |
| INMDInmode Ltd | 9/10 | 98 | 81 | 0,0% | 9,6 | 1,3 | −7,5% | € 808,2 mln. | Caution:Earnings quality |
| UHSUniversal Health Services | 10/10 | 98 | 88 | 0,4%net ≈ 0,4% | 7,3 | 1,5 | −8,4% | € 9,9 mld. | |
| CICigna | 9/10 | 98 | 66 | 2,1%net ≈ 1,8% | 11,9 | 1,8 | −2,0% | € 68,4 mld. | |
| HRMYHarmony Biosciences Holdings | 10/10 | 97 | 93 | 0,0% | 12,1 | 2,2 | +39,8% | € 2 mld. | |
| MDPediatrix Medical Group | 10/10 | 97 | 82 | 0,0% | 12,6 | 2,5 | +68,2% | € 2 mld. | |
| ADUSAddus HomeCare Corp | 9/10 | 96 | 71 | 0,0% | 20,7 | 1,9 | +1,8% | € 1,9 mld. | Caution:Dilution |
| ELVElevance Health | 10/10 | 96 | 83 | 1,6%net ≈ 1,3% | 18,7 | 2,1 | +24,6% | € 82,9 mld. |
Net = estimated yield after tax for: Cyprus resident, non-domiciled. An estimate, not tax advice. How we estimate tax
How the screener works
Every instrument is compared with its peers — the same sector and region for companies, the same type for funds — on published rules: Value, Quality, Trend (momentum), Stability (low volatility) and Dividend Safety. Each factor is a percentile from 0 to 100, and the Smart Score (1–10) combines them.
Presets are fixed, published rules, the same for every visitor; the filters you add only narrow the list. Nothing here is a recommendation to buy or sell: a screen is a starting point for your own research.
Serious warnings (for example NAV erosion or financial distress) cap the score, and the value, quality and dividend presets leave such instruments out. The data refreshes every trading day.
Dividend calendar →Dividend calculator →Methodology and sources →
Hier opzeggen · EU-consumenten: 14 dagen bedenktijd bij aankoop.